Bharat Immunologicals & Biologicals (BOM:524663) 3-Year Revenue Growth Rate : -12.60% (As of Sep. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals 3-Year Revenue Growth Rate?

Bharat Immunologicals & Biologicals's Revenue per Share for the three months ended in Sep. 2023 was ₹0.00.

During the past 12 months, Bharat Immunologicals & Biologicals's average Revenue per Share Growth Rate was -89.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -12.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was -11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Bharat Immunologicals & Biologicals was 329.90% per year. The lowest was -42.70% per year. And the median was -9.50% per year.

Competitive Comparison of Bharat Immunologicals & Biologicals's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bharat Immunologicals & Biologicals's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's 3-Year Revenue Growth Rate falls into.

Bharat Immunologicals & Biologicals 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Bharat Immunologicals & Biologicals (BOM:524663) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Bharat Immunologicals & Biologicals 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203

Website

http://www.bibcol.sciencecentral.in

Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines